124 related articles for article (PubMed ID: 25260784)
1. Multivisceral Resection for Locally Advanced Rectal Cancer: Prognostic Factors Influencing Outcome.
Mañas MJ; Espín E; López-Cano M; Vallribera F; Armengol-Carrasco M
Scand J Surg; 2015 Sep; 104(3):154-60. PubMed ID: 25260784
[TBL] [Abstract][Full Text] [Related]
2. Multivisceral resections for locally advanced rectal cancer.
Derici H; Unalp HR; Kamer E; Bozdag AD; Tansug T; Nazli O; Kara C
Colorectal Dis; 2008 Jun; 10(5):453-9. PubMed ID: 18070183
[TBL] [Abstract][Full Text] [Related]
3. The influence of the number of retrieved lymph nodes on staging and survival in patients with stage II and III rectal cancer undergoing tumor-specific mesorectal excision.
Kim YW; Kim NK; Min BS; Lee KY; Sohn SK; Cho CH
Ann Surg; 2009 Jun; 249(6):965-72. PubMed ID: 19474683
[TBL] [Abstract][Full Text] [Related]
4. Multivisceral resection for colon carcinoma.
Croner RS; Merkel S; Papadopoulos T; Schellerer V; Hohenberger W; Goehl J
Dis Colon Rectum; 2009 Aug; 52(8):1381-6. PubMed ID: 19617748
[TBL] [Abstract][Full Text] [Related]
5. Long-term oncologic outcomes of laparoscopic vs open surgery for stages II and III rectal cancer: A retrospective cohort study.
Zhou ZX; Zhao LY; Lin T; Liu H; Deng HJ; Zhu HL; Yan J; Li GX
World J Gastroenterol; 2015 May; 21(18):5505-12. PubMed ID: 25987773
[TBL] [Abstract][Full Text] [Related]
6. Impact of postoperative complications on long-term survival after resection for rectal cancer.
Mrak K; Eberl T; Laske A; Jagoditsch M; Fritz J; Tschmelitsch J
Dis Colon Rectum; 2013 Jan; 56(1):20-8. PubMed ID: 23222276
[TBL] [Abstract][Full Text] [Related]
7. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
8. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
9. Surgical salvage of recurrent rectal cancer after transanal excision.
Weiser MR; Landmann RG; Wong WD; Shia J; Guillem JG; Temple LK; Minsky BD; Cohen AM; Paty PB
Dis Colon Rectum; 2005 Jun; 48(6):1169-75. PubMed ID: 15793645
[TBL] [Abstract][Full Text] [Related]
10. Long-term results of surgical resection of locally advanced colorectal carcinoma.
Eisenberg SB; Kraybill WG; Lopez MJ
Surgery; 1990 Oct; 108(4):779-85; discussion 785-6. PubMed ID: 2218891
[TBL] [Abstract][Full Text] [Related]
11. Utilization of interventional radiology in the postoperative management of patients after surgery for locally advanced and recurrent rectal cancer.
Llaguna OH; Calvo BF; Stitzenberg KB; Deal AM; Burke CT; Dixon RG; Stavas JM; Meyers MO
Am Surg; 2011 Aug; 77(8):1086-90. PubMed ID: 21944529
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of extramural vascular invasion in T4 rectal cancer.
Bhangu A; Fitzgerald JE; Slesser A; Northover JM; Faiz O; Tekkis P
Colorectal Dis; 2013 Nov; 15(11):e665-71. PubMed ID: 24103008
[TBL] [Abstract][Full Text] [Related]
13. Outcomes of resection of stage IV rectal cancer with mesorectal excision.
Law WL; Chu KW
J Surg Oncol; 2006 Jun; 93(7):523-8. PubMed ID: 16705728
[TBL] [Abstract][Full Text] [Related]
14. Predictive factors in locally advanced rectal cancer treated with preoperative hyperfractionated and accelerated radiotherapy.
Bouzourene H; Bosman FT; Matter M; Coucke P
Hum Pathol; 2003 Jun; 34(6):541-8. PubMed ID: 12827607
[TBL] [Abstract][Full Text] [Related]
15. Intra-operative perforation is an important predictor of local recurrence and impaired survival after abdominoperineal resection for rectal cancer.
Bülow S; Christensen IJ; Iversen LH; Harling H;
Colorectal Dis; 2011 Nov; 13(11):1256-64. PubMed ID: 20958912
[TBL] [Abstract][Full Text] [Related]
16. Multivisceral resection for primary locally advanced rectal carcinoma.
Harris DA; Davies M; Lucas MG; Drew P; Carr ND; Beynon J;
Br J Surg; 2011 Apr; 98(4):582-8. PubMed ID: 21656723
[TBL] [Abstract][Full Text] [Related]
17. Multivisceral resection for advanced rectal cancer: outcomes and experience at a single institution.
Crawshaw BP; Augestad KM; Keller DS; Nobel T; Swendseid B; Champagne BJ; Stein SL; Delaney CP; Reynolds HL
Am J Surg; 2015 Mar; 209(3):526-31. PubMed ID: 25577290
[TBL] [Abstract][Full Text] [Related]
18. Factors associated with oncologic outcomes after abdominoperineal resection compared with restorative resection for low rectal cancer: patient- and tumor-related or technical factors only?
Reshef A; Lavery I; Kiran RP
Dis Colon Rectum; 2012 Jan; 55(1):51-8. PubMed ID: 22156867
[TBL] [Abstract][Full Text] [Related]
19. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
20. Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO/ARO/AIO-94 trial.
Fokas E; Liersch T; Fietkau R; Hohenberger W; Beissbarth T; Hess C; Becker H; Ghadimi M; Mrak K; Merkel S; Raab HR; Sauer R; Wittekind C; Rödel C
J Clin Oncol; 2014 May; 32(15):1554-62. PubMed ID: 24752056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
